1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015

Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015" provides data on the Functional (Non Ulcer) Dyspepsia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Functional (Non Ulcer) Dyspepsia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Functional (Non Ulcer) Dyspepsia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Functional (Non Ulcer) Dyspepsia Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Functional (Non Ulcer) Dyspepsia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Functional (Non Ulcer) Dyspepsia 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Zeria Pharmaceutical Co Ltd 32
Clinical Trial Overview of Zeria Pharmaceutical Co Ltd 32
Astellas Pharma Inc. 33
Clinical Trial Overview of Astellas Pharma Inc. 33
Actavis plc 34
Clinical Trial Overview of Actavis plc 34
Zydus Cadila Healthcare Limited 35
Clinical Trial Overview of Zydus Cadila Healthcare Limited 35
Ironwood Pharmaceuticals, Inc. 36
Clinical Trial Overview of Ironwood Pharmaceuticals, Inc. 36
Eisai Co., Ltd. 37
Clinical Trial Overview of Eisai Co., Ltd. 37
Dong-A Socio Group 38
Clinical Trial Overview of Dong-A Socio Group 38
Chemo Espana, S.A. 39
Clinical Trial Overview of Chemo Espana, S.A. 39
Aravis Limited 40
Clinical Trial Overview of Aravis Limited 40
Ajinomoto Co., Inc. 41
Clinical Trial Overview of Ajinomoto Co., Inc. 41
Clinical Trial Overview of Top Institutes / Government 42
Chengdu University of Traditional Chinese Medicine 42
Clinical Trial Overview of Chengdu University of Traditional Chinese Medicine 42
Academic Medical Center 43
Clinical Trial Overview of Academic Medical Center 43
Aga Khan University 44
Clinical Trial Overview of Aga Khan University 44
Chiba University 45
Clinical Trial Overview of Chiba University 45
China Academy of Chinese Medical Sciences 46
Clinical Trial Overview of China Academy of Chinese Medical Sciences 46
Chinese University of Hong Kong 47
Clinical Trial Overview of Chinese University of Hong Kong 47
Chung-Ang University Hospital 48
Clinical Trial Overview of Chung-Ang University Hospital 48
Hyogo College Of Medicine 49
Clinical Trial Overview of Hyogo College Of Medicine 49
Keio University 50
Clinical Trial Overview of Keio University 50
Korea Health Industry Development Institute 51
Clinical Trial Overview of Korea Health Industry Development Institute 51
Five Key Clinical Profiles 52
Appendix 73
Abbreviations 73
Definitions 73
Research Methodology 74
Secondary Research 74
About GlobalData 75
Contact Us 75
Disclaimer 75
Source 75

List of Tables
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Region, 2015* 7
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Functional (Non Ulcer) Dyspepsia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Zeria Pharmaceutical Co Ltd, 2015* 32
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015* 33
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Actavis plc, 2015* 34
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Zydus Cadila Healthcare Limited, 2015* 35
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ironwood Pharmaceuticals, Inc., 2015* 36
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2015* 37
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dong-A Socio Group, 2015* 38
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2015* 39
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aravis Limited, 2015* 40
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ajinomoto Co., Inc., 2015* 41
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chengdu University of Traditional Chinese Medicine, 2015* 42
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2015* 43
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2015* 44
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2015* 45
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by China Academy of Chinese Medical Sciences, 2015* 46
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 47
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Chung-Ang University Hospital, 2015* 48
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hyogo College Of Medicine, 2015* 49
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Keio University, 2015* 50
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials Market, Global, Clinical Trials by Korea Health Industry Development Institute, 2015* 51

List of Figures
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, G7 Countries (%), 2015* 15
Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Functional (Non Ulcer) Dyspepsia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Functional (Non Ulcer) Dyspepsia to Gastrointestinal Clinical Trials, E7 Countries (%), 2015* 18
Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Functional (Non Ulcer) Dyspepsia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Functional (Non Ulcer) Dyspepsia Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Functional (Non Ulcer) Dyspepsia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Functional (Non Ulcer) Dyspepsia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.